Alternative medicinefromWIRED2 months agoPatients Are Left With Few Options as GLP-1 Copycats DisappearAccess to weight loss medications like Ozempic and Zepbound is uncertain for many as compounded versions exit the market with drug supply stabilization.
UK newsfromwww.independent.co.uk3 months agoBrexit costs denying NHS cancer patients life-saving drugs, report warnsBrexit is significantly hindering British cancer patients' access to new treatments and clinical trials.